안구테라퓨틱스(Ocular Therapeutix, Inc.)
DE ˙ DB ˙ US67576A1007
€7.15 ↑0.25 (3.62%)
2026-06-04
주가
SecurityDE:0OT / Ocular Therapeutix, Inc.
InstitutionAlliancebernstein L.p.
Latest Disclosed Ownership4,129,687 shares
Latest Disclosed Value $ 50,134,400
Alliancebernstein L.p. reports 4.89% decrease in ownership of 0OT / Ocular Therapeutix, Inc.

On May 15, 2026 - Alliancebernstein L.p. filed a 13F-HR form disclosing ownership of 4,129,687 shares of Ocular Therapeutix, Inc. (DE:0OT) valued at $27,437,640 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 4,341,951 shares of Ocular Therapeutix, Inc.. This represents a change in shares of -4.89% during the quarter. The current value of the position is $29,527,262 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F OCULAR THERAPEUTIX COM 67576A100 4,129,687 -212,264 -4.89 50,134 -4.89 0.0136
2026-02-17 2025-12-31 13F OCULAR THERAPEUTIX COM 67576A100 4,341,951 917,512 26.79 52,711 31.68 0.0166
2025-11-14 2025-09-30 13F OCULAR THERAPEUTIX COM 67576A100 3,424,439 3,261,619 2,003.21 40,032 2,551.06 0.0126
2025-08-14 2025-06-30 13F OCULAR THERAPEUTIX COM 67576A100 162,820 0 0.00 1,511 26.57 0.0005
2025-05-15 2025-03-31 13F OCULAR THERAPEUTIX COM 67576A100 162,820 0 0.00 1,193 -14.17 0.0004
2025-02-12 2024-12-31 13F OCULAR THERAPEUTIX COM 67576A100 162,820 0 0.00 1,390 -1.84 0.0005
2024-11-14 2024-09-30 13F OCULAR THERAPEUTIX COM 67576A100 162,820 0 0.00 1,417 27.22 0.0005
2024-08-14 2024-06-30 13F OCULAR THERAPEUTIX COM 67576A100 162,820 57,870 55.14 1,114 16.54 0.0004
2024-05-14 2024-03-31 13F OCULAR THERAPEUTIX COM 67576A100 104,950 10,600 11.23 955 127.38 0.0003
2024-02-14 2023-12-31 13F OCULAR THERAPEUTIX COM 67576A100 94,350 0 0.00 421 41.89 0.0002
2023-11-14 2023-09-30 13F OCULAR THERAPEUTIX COM 67576A100 94,350 5,750 6.49 296 -35.23 0.0001
2023-08-15 2023-06-30 13F OCULAR THERAPEUTIX COM 67576A100 88,600 -4,900 -5.24 457 -7.11 0.0002
2023-05-15 2023-03-31 13F OCULAR THERAPEUTIX COM 67576A100 93,500 0 0.00 493 87.79 0.0002
2023-02-15 2022-12-31 13F OCULAR THERAPEUTIX COM 67576A100 93,500 7,100 8.22 263 -27.02 0.0001
2022-11-15 2022-09-30 13F OCULAR THERAPEUTIX COM 67576A100 86,400 -5,300 -5.78 359 -2.71 0.0002
2022-08-15 2022-06-30 13F OCULAR THERAPEUTIX COM 67576A100 91,700 4,900 5.65 369 -14.19 0.0002
2022-05-13 2022-03-31 13F OCULAR THERAPEUTIX COM 67576A100 86,800 200 0.23 430 -28.81 0.0002
2022-02-14 2021-12-31 13F OCULAR THERAPEUTIX COM 67576A100 86,600 0 0.00 604 -30.25 0.0002
2021-11-10 2021-09-30 13F OCULAR THERAPEUTIX COM 67576A100 86,600 0 0.00 866 -29.48 0.0003
2021-07-30 2021-06-30 13F OCULAR THERAPEUTIX COM 67576A100 86,600 0 0.00 1,228 -13.58 0.0005
2021-05-06 2021-03-31 13F OCULAR THERAPEUTIX COM 67576A100 86,600 2,200 2.61 1,421 -18.66 0.0006
2021-02-08 2020-12-31 13F OCULAR THERAPEUTIX COM 67576A100 84,400 4,000 4.98 1,747 185.46 0.0008
2020-11-12 2020-09-30 13F OCULAR THERAPEUTIX COM 67576A100 80,400 0 0.00 612 -8.66 0.0003
2020-08-13 2020-06-30 13F OCULAR THERAPEUTIX COM 67576A100 80,400 -12,200 -13.17 670 46.29 0.0004
2020-05-14 2020-03-31 13F OCULAR THERAPEUTIX COM 67576A100 92,600 34,700 59.93 458 100.00 0.0003
2020-02-18 2019-12-31 13F OCULAR THERAPEUTIX COM 67576A100 57,900 0 0.00 229 30.11 0.0001
2019-11-14 2019-09-30 13F OCULAR THERAPEUTIX COM 67576A100 57,900 -4,600 -7.36 176 -36.00 0.0001
2019-08-14 2019-06-30 13F OCULAR THERAPEUTIX COM 67576A100 62,500 14,800 31.03 275 45.50 0.0002
2019-05-14 2019-03-31 13F OCULAR THERAPEUTIX COM 67576A100 47,700 -3,400 -6.65 189 -6.90 0.0001
2019-02-13 2018-12-31 13F OCULAR THERAPEUTIX COM 67576A100 51,100 0 0.00 203 -42.33 0.0002
2018-11-08 2018-09-30 13F OCULAR THERAPEUTIX COM 67576A100 51,100 4,100 8.72 352 11.04 0.0002
2018-08-13 2018-06-30 13F OCULAR THERAPEUTIX COM 67576A100 47,000 2,600 5.86 317 9.69 0.0002
2018-05-14 2018-03-31 13F OCULAR THERAPEUTIX COM 67576A100 44,400 0 0.00 289 45.96 0.0002
2018-02-13 2017-12-31 13F OCULAR THERAPEUTIX COM 67576A100 44,400 2,700 6.47 198 -23.26 0.0001
2017-11-13 2017-09-30 13F OCULAR THERAPEUTIX COM 67576A100 41,700 0 0.00 258 -33.33 0.0002
2017-08-10 2017-06-30 13F OCULAR THERAPEUTIX COM 67576A100 41,700 14,400 52.75 387 52.96 0.0003
2017-05-11 2017-03-31 13F OCULAR THERAPEUTIX COM 67576A100 27,300 0 0.00 253 10.48 0.0002
2017-02-13 2016-12-31 13F OCULAR THERAPEUTIX COM 67576A100 27,300 0 0.00 229 21.81 0.0002
2016-11-10 2016-09-30 13F OCULAR THERAPEUTIX COM 67576A100 27,300 0 0.00 188 39.26 0.0002
2016-08-11 2016-06-30 13F OCULAR THERAPEUTIX COM 67576A100 27,300 15,300 127.50 135 16.38 0.0001
2016-05-13 2016-03-31 13F OCULAR THERAPEUTIX COM 67576A100 12,000 -69,260 -85.23 116 -84.76 0.0001
2016-02-16 2015-12-31 13F/A-1 OCULAR THERAPEUTIX COM 67576A100 81,260 22,716 38.80 761 -7.53 0.0006
2016-02-12 2015-12-31 13F OCULAR THERAPEUTIX COM 67576A100 81,260 1,143
2015-11-13 2015-09-30 13F OCULAR THERAPEUTIX COM 67576A100 58,544 46,544 387.87 823 226.59 0.0007
2015-08-14 2015-06-30 13F OCULAR THERAPEUTIX COM 67576A100 12,000 7,600 172.73 252 36.22 0.0002
2015-05-13 2015-03-31 13F OCULAR THERAPEUTIX COM 67576A100 4,400 4,400 185 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.